Nature Network - Notices from Investment in Biotech/Pharma Sector http://network.nature.com/group/G0F374FBC Latest group notices from the administrators of Investment in Biotech/Pharma Sector en-us 40 VPHM Tue, 15 Jul 2008 13:42:55 -0000 http://network.nature.com/groups/G0F374FBC/notice/2008/07/15/vphm http://network.nature.com/groups/G0F374FBC/notice/2008/07/15/vphm What do they do? Are their drugs working?

]]> July's PICK Mon, 23 Jul 2007 05:42:49 -0000 http://network.nature.com/groups/G0F374FBC/notice/2007/07/23/julys-pick http://network.nature.com/groups/G0F374FBC/notice/2007/07/23/julys-pick Guys,
June’s pick was great! It is improving my profolio great time. CHTP went up to 7.35 at one point, and I was almost have it sold for a 50% return in a month. But I am hoping it will go up to 8.00 since all the clinical study will be in couple months. Anyway, I will stick to the plan. Sell above $7.

July’s pick is VRTX. It is a very small company. Their focus is VX-950. The clinical trial is in fast track, meaning there is a communication with the FDA. It should start their pharse 3 soon.

What I like about them: they have profit form a existing drugs. That mean they can do science. They have product until other small biotech

What I don’t like, the CEO is from Harvard. I talk to some officers, they don’t sounds very intelligent.
I think this company will be a timely buy and sell.

Buy below $30, sell above $35.
Hold up to 1 to 2 year
Trade on your own risk

]]>